Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase1, Single Dose, Crossover Study to Determine Bioequivalence

This study has been completed.
Information provided by:
Pfizer Identifier:
First received: November 5, 2008
Last updated: September 8, 2010
Last verified: September 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)